학술논문
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer
Document Type
Article
Author
Source
In Cancer / Radiothérapie September 2022 26(5):670-677
Subject
Language
ISSN
1278-3218